Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group - Eichenauer, D A; Fuchs, M; Pluetschow, A (Blood, 2011)
et al.